Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Psoriasis is a chronic non-contagious disease in which a person’s immune system sends faulty signals directing skin cells to grow too quickly.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Psoriasis Treatment market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Psoriasis Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Psoriasis Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novartis International AG
Eli Lilly
AbbVie and Amgen
Johnson & Johnson
By Type:
TNF Inhibitors
Phosphodiesterase Inhibitors
Interleukin Blockers
Others
By End-User:
Oral
Tropical
Injectable
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Psoriasis Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 China Psoriasis Treatment Market Size and Growth Rate of TNF Inhibitors from 2016 to 2027
-
1.3.2 China Psoriasis Treatment Market Size and Growth Rate of Phosphodiesterase Inhibitors from 2016 to 2027
-
1.3.3 China Psoriasis Treatment Market Size and Growth Rate of Interleukin Blockers from 2016 to 2027
-
1.3.4 China Psoriasis Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Psoriasis Treatment Market Size and Growth Rate of Oral from 2016 to 2027
-
1.4.2 China Psoriasis Treatment Market Size and Growth Rate of Tropical from 2016 to 2027
-
1.4.3 China Psoriasis Treatment Market Size and Growth Rate of Injectable from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Psoriasis Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Psoriasis Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of TNF Inhibitors
-
3.4.2 Market Size and Growth Rate of Phosphodiesterase Inhibitors
-
3.4.3 Market Size and Growth Rate of Interleukin Blockers
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Psoriasis Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Psoriasis Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Psoriasis Treatment in Oral
-
4.4.2 Market Size and Growth Rate of Psoriasis Treatment in Tropical
-
4.4.3 Market Size and Growth Rate of Psoriasis Treatment in Injectable
5 Market Analysis by Regions
-
5.1 China Psoriasis Treatment Production Analysis by Regions
-
5.2 China Psoriasis Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Psoriasis Treatment Landscape Analysis
-
6.1 North China Psoriasis Treatment Landscape Analysis by Major Types
-
6.2 North China Psoriasis Treatment Landscape Analysis by Major End-Users
7 Central China Psoriasis Treatment Landscape Analysis
-
7.1 Central China Psoriasis Treatment Landscape Analysis by Major Types
-
7.2 Central China Psoriasis Treatment Landscape Analysis by Major End-Users
8 South China Psoriasis Treatment Landscape Analysis
-
8.1 South China Psoriasis Treatment Landscape Analysis by Major Types
-
8.2 South China Psoriasis Treatment Landscape Analysis by Major End-Users
9 East China Psoriasis Treatment Landscape Analysis
-
9.1 East China Psoriasis Treatment Landscape Analysis by Major Types
-
9.2 East China Psoriasis Treatment Landscape Analysis by Major End-Users
10 Northeast China Psoriasis Treatment Landscape Analysis
-
10.1 Northeast China Psoriasis Treatment Landscape Analysis by Major Types
-
10.2 Northeast China Psoriasis Treatment Landscape Analysis by Major End-Users
11 Southwest China Psoriasis Treatment Landscape Analysis
-
11.1 Southwest China Psoriasis Treatment Landscape Analysis by Major Types
-
11.2 Southwest China Psoriasis Treatment Landscape Analysis by Major End-Users
12 Northwest China Psoriasis Treatment Landscape Analysis
-
12.1 Northwest China Psoriasis Treatment Landscape Analysis by Major Types
-
12.2 Northwest China Psoriasis Treatment Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Novartis International AG
-
13.1.1 Novartis International AG Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Eli Lilly
-
13.2.1 Eli Lilly Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 AbbVie and Amgen
-
13.3.1 AbbVie and Amgen Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Johnson & Johnson
-
13.4.1 Johnson & Johnson Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Psoriasis Treatment Market Size and Growth Rate of TNF Inhibitors from 2016 to 2027
-
Figure China Psoriasis Treatment Market Size and Growth Rate of Phosphodiesterase Inhibitors from 2016 to 2027
-
Figure China Psoriasis Treatment Market Size and Growth Rate of Interleukin Blockers from 2016 to 2027
-
Figure China Psoriasis Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Psoriasis Treatment Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure China Psoriasis Treatment Market Size and Growth Rate of Tropical from 2016 to 2027
-
Figure China Psoriasis Treatment Market Size and Growth Rate of Injectable from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Psoriasis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Psoriasis Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Psoriasis Treatment
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Psoriasis Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Psoriasis Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of TNF Inhibitors
-
Figure Market Size and Growth Rate of Phosphodiesterase Inhibitors
-
Figure Market Size and Growth Rate of Interleukin Blockers
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Psoriasis Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Psoriasis Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Tropical
-
Figure Market Size and Growth Rate of Injectable
-
Table China Psoriasis Treatment Production by Regions
-
Table China Psoriasis Treatment Production Share by Regions
-
Figure China Psoriasis Treatment Production Share by Regions in 2016
-
Figure China Psoriasis Treatment Production Share by Regions in 2021
-
Figure China Psoriasis Treatment Production Share by Regions in 2027
-
Table China Psoriasis Treatment Consumption by Regions
-
Table China Psoriasis Treatment Consumption Share by Regions
-
Figure China Psoriasis Treatment Consumption Share by Regions in 2016
-
Figure China Psoriasis Treatment Consumption Share by Regions in 2021
-
Figure China Psoriasis Treatment Consumption Share by Regions in 2027
-
Table North China Psoriasis Treatment Consumption by Types from 2016 to 2027
-
Table North China Psoriasis Treatment Consumption Share by Types from 2016 to 2027
-
Figure North China Psoriasis Treatment Consumption Share by Types in 2016
-
Figure North China Psoriasis Treatment Consumption Share by Types in 2021
-
Figure North China Psoriasis Treatment Consumption Share by Types in 2027
-
Table North China Psoriasis Treatment Consumption by End-Users from 2016 to 2027
-
Table North China Psoriasis Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure North China Psoriasis Treatment Consumption Share by End-Users in 2016
-
Figure North China Psoriasis Treatment Consumption Share by End-Users in 2021
-
Figure North China Psoriasis Treatment Consumption Share by End-Users in 2027
-
Table Central China Psoriasis Treatment Consumption by Types from 2016 to 2027
-
Table Central China Psoriasis Treatment Consumption Share by Types from 2016 to 2027
-
Figure Central China Psoriasis Treatment Consumption Share by Types in 2016
-
Figure Central China Psoriasis Treatment Consumption Share by Types in 2021
-
Figure Central China Psoriasis Treatment Consumption Share by Types in 2027
-
Table Central China Psoriasis Treatment Consumption by End-Users from 2016 to 2027
-
Table Central China Psoriasis Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Psoriasis Treatment Consumption Share by End-Users in 2016
-
Figure Central China Psoriasis Treatment Consumption Share by End-Users in 2021
-
Figure Central China Psoriasis Treatment Consumption Share by End-Users in 2027
-
Table South China Psoriasis Treatment Consumption by Types from 2016 to 2027
-
Table South China Psoriasis Treatment Consumption Share by Types from 2016 to 2027
-
Figure South China Psoriasis Treatment Consumption Share by Types in 2016
-
Figure South China Psoriasis Treatment Consumption Share by Types in 2021
-
Figure South China Psoriasis Treatment Consumption Share by Types in 2027
-
Table South China Psoriasis Treatment Consumption by End-Users from 2016 to 2027
-
Table South China Psoriasis Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South China Psoriasis Treatment Consumption Share by End-Users in 2016
-
Figure South China Psoriasis Treatment Consumption Share by End-Users in 2021
-
Figure South China Psoriasis Treatment Consumption Share by End-Users in 2027
-
Table East China Psoriasis Treatment Consumption by Types from 2016 to 2027
-
Table East China Psoriasis Treatment Consumption Share by Types from 2016 to 2027
-
Figure East China Psoriasis Treatment Consumption Share by Types in 2016
-
Figure East China Psoriasis Treatment Consumption Share by Types in 2021
-
Figure East China Psoriasis Treatment Consumption Share by Types in 2027
-
Table East China Psoriasis Treatment Consumption by End-Users from 2016 to 2027
-
Table East China Psoriasis Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure East China Psoriasis Treatment Consumption Share by End-Users in 2016
-
Figure East China Psoriasis Treatment Consumption Share by End-Users in 2021
-
Figure East China Psoriasis Treatment Consumption Share by End-Users in 2027
-
Table Northeast China Psoriasis Treatment Consumption by Types from 2016 to 2027
-
Table Northeast China Psoriasis Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Psoriasis Treatment Consumption Share by Types in 2016
-
Figure Northeast China Psoriasis Treatment Consumption Share by Types in 2021
-
Figure Northeast China Psoriasis Treatment Consumption Share by Types in 2027
-
Table Northeast China Psoriasis Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast China Psoriasis Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Psoriasis Treatment Consumption Share by End-Users in 2016
-
Figure Northeast China Psoriasis Treatment Consumption Share by End-Users in 2021
-
Figure Northeast China Psoriasis Treatment Consumption Share by End-Users in 2027
-
Table Southwest China Psoriasis Treatment Consumption by Types from 2016 to 2027
-
Table Southwest China Psoriasis Treatment Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Psoriasis Treatment Consumption Share by Types in 2016
-
Figure Southwest China Psoriasis Treatment Consumption Share by Types in 2021
-
Figure Southwest China Psoriasis Treatment Consumption Share by Types in 2027
-
Table Southwest China Psoriasis Treatment Consumption by End-Users from 2016 to 2027
-
Table Southwest China Psoriasis Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Psoriasis Treatment Consumption Share by End-Users in 2016
-
Figure Southwest China Psoriasis Treatment Consumption Share by End-Users in 2021
-
Figure Southwest China Psoriasis Treatment Consumption Share by End-Users in 2027
-
Table Northwest China Psoriasis Treatment Consumption by Types from 2016 to 2027
-
Table Northwest China Psoriasis Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Psoriasis Treatment Consumption Share by Types in 2016
-
Figure Northwest China Psoriasis Treatment Consumption Share by Types in 2021
-
Figure Northwest China Psoriasis Treatment Consumption Share by Types in 2027
-
Table Northwest China Psoriasis Treatment Consumption by End-Users from 2016 to 2027
-
Table Northwest China Psoriasis Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Psoriasis Treatment Consumption Share by End-Users in 2016
-
Figure Northwest China Psoriasis Treatment Consumption Share by End-Users in 2021
-
Figure Northwest China Psoriasis Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novartis International AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International AG
-
Figure Sales and Growth Rate Analysis of Novartis International AG
-
Figure Revenue and Market Share Analysis of Novartis International AG
-
Table Product and Service Introduction of Novartis International AG
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of AbbVie and Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie and Amgen
-
Figure Sales and Growth Rate Analysis of AbbVie and Amgen
-
Figure Revenue and Market Share Analysis of AbbVie and Amgen
-
Table Product and Service Introduction of AbbVie and Amgen
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
